The Global Epigenetics Market is on an accelerated growth trajectory, driven by cutting‑edge advancements in molecular diagnostics, personalized medicine, and cancer research. According to The Insight Partners, the market is forecast to expand from US$ 11.12 billion in 2024 to an estimated US$ 35.84 billion by 2031, registering a robust CAGR of 18.3% during the 2025‑2031 period. This surge is...